Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Neurotransmitter Agents
1.2.3 Neuroprotective Agents
1.2.4 Biologics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Multiple Sclerosis [MS]
1.3.3 Alzheimer’s Disease
1.3.4 Parkinson's Disease
1.3.5 Acute Migraine
1.3.6 Autism
1.3.7 Narcolepsy
1.3.8 Amyotrophic Lateral Sclerosis [ALS]
1.3.9 Attention Deficit Hyperactivity Disorder [ADHD]
1.3.10 Spinal Muscular Atrophy
1.3.11 Huntington's Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Treatment Market Perspective (2018-2033)
2.2 Neurodegenerative Disease Treatment Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neurodegenerative Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Neurodegenerative Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Neurodegenerative Disease Treatment Market Dynamics
2.3.1 Neurodegenerative Disease Treatment Industry Trends
2.3.2 Neurodegenerative Disease Treatment Market Drivers
2.3.3 Neurodegenerative Disease Treatment Market Challenges
2.3.4 Neurodegenerative Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Treatment Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Neurodegenerative Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Neurodegenerative Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurodegenerative Disease Treatment Revenue
3.4 Global Neurodegenerative Disease Treatment Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Treatment Revenue in 2022
3.5 Neurodegenerative Disease Treatment Key Players Head office and Area Served
3.6 Key Players Neurodegenerative Disease Treatment Product Solution and Service
3.7 Date of Enter into Neurodegenerative Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Treatment Breakdown Data by Type
4.1 Global Neurodegenerative Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Neurodegenerative Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Neurodegenerative Disease Treatment Breakdown Data by Application
5.1 Global Neurodegenerative Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Neurodegenerative Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neurodegenerative Disease Treatment Market Size (2018-2033)
6.2 North America Neurodegenerative Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neurodegenerative Disease Treatment Market Size by Country (2018-2023)
6.4 North America Neurodegenerative Disease Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Treatment Market Size (2018-2033)
7.2 Europe Neurodegenerative Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neurodegenerative Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Neurodegenerative Disease Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Treatment Market Size (2018-2033)
8.2 Asia-Pacific Neurodegenerative Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neurodegenerative Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Neurodegenerative Disease Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Treatment Market Size (2018-2033)
9.2 Latin America Neurodegenerative Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neurodegenerative Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Neurodegenerative Disease Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Treatment Market Size (2018-2033)
10.2 Middle East & Africa Neurodegenerative Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Detail
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Neurodegenerative Disease Treatment Introduction
11.1.4 Allergan plc Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.1.5 Allergan plc Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Neurodegenerative Disease Treatment Introduction
11.2.4 Bayer AG Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.2.5 Bayer AG Recent Development
11.3 F. Hoffmann La-Roche Ltd.
11.3.1 F. Hoffmann La-Roche Ltd. Company Detail
11.3.2 F. Hoffmann La-Roche Ltd. Business Overview
11.3.3 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Introduction
11.3.4 F. Hoffmann La-Roche Ltd. Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.3.5 F. Hoffmann La-Roche Ltd. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Neurodegenerative Disease Treatment Introduction
11.4.4 GlaxoSmithKline plc Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Neurodegenerative Disease Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Neurodegenerative Disease Treatment Introduction
11.6.4 Merck KGaA Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Neurodegenerative Disease Treatment Introduction
11.7.4 Novartis AG Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.7.5 Novartis AG Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Detail
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Neurodegenerative Disease Treatment Introduction
11.8.4 Pfizer, Inc. Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.8.5 Pfizer, Inc. Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Neurodegenerative Disease Treatment Introduction
11.9.4 Sanofi Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Neurodegenerative Disease Treatment Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurodegenerative Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Neurotransmitter Agents
Table 3. Key Players of Neuroprotective Agents
Table 4. Key Players of Biologics
Table 5. Key Players of Others
Table 6. Global Neurodegenerative Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Neurodegenerative Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Neurodegenerative Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Neurodegenerative Disease Treatment Market Share by Region (2018-2023)
Table 10. Global Neurodegenerative Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Neurodegenerative Disease Treatment Market Share by Region (2024-2033)
Table 12. Neurodegenerative Disease Treatment Market Trends
Table 13. Neurodegenerative Disease Treatment Market Drivers
Table 14. Neurodegenerative Disease Treatment Market Challenges
Table 15. Neurodegenerative Disease Treatment Market Restraints
Table 16. Global Neurodegenerative Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Neurodegenerative Disease Treatment Market Share by Players (2018-2023)
Table 18. Global Top Neurodegenerative Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment as of 2022)
Table 19. Ranking of Global Top Neurodegenerative Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Neurodegenerative Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Neurodegenerative Disease Treatment Product Solution and Service
Table 23. Date of Enter into Neurodegenerative Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurodegenerative Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Neurodegenerative Disease Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Neurodegenerative Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Neurodegenerative Disease Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Neurodegenerative Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Neurodegenerative Disease Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Neurodegenerative Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Neurodegenerative Disease Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Neurodegenerative Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Neurodegenerative Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Neurodegenerative Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Neurodegenerative Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Neurodegenerative Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Neurodegenerative Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Neurodegenerative Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Neurodegenerative Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Neurodegenerative Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Neurodegenerative Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Neurodegenerative Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Neurodegenerative Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Neurodegenerative Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Allergan plc Company Detail
Table 49. Allergan plc Business Overview
Table 50. Allergan plc Neurodegenerative Disease Treatment Product
Table 51. Allergan plc Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 52. Allergan plc Recent Development
Table 53. Bayer AG Company Detail
Table 54. Bayer AG Business Overview
Table 55. Bayer AG Neurodegenerative Disease Treatment Product
Table 56. Bayer AG Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 57. Bayer AG Recent Development
Table 58. F. Hoffmann La-Roche Ltd. Company Detail
Table 59. F. Hoffmann La-Roche Ltd. Business Overview
Table 60. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product
Table 61. F. Hoffmann La-Roche Ltd. Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 62. F. Hoffmann La-Roche Ltd. Recent Development
Table 63. GlaxoSmithKline plc Company Detail
Table 64. GlaxoSmithKline plc Business Overview
Table 65. GlaxoSmithKline plc Neurodegenerative Disease Treatment Product
Table 66. GlaxoSmithKline plc Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 67. GlaxoSmithKline plc Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Neurodegenerative Disease Treatment Product
Table 71. Johnson & Johnson Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Merck KGaA Company Detail
Table 74. Merck KGaA Business Overview
Table 75. Merck KGaA Neurodegenerative Disease Treatment Product
Table 76. Merck KGaA Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 77. Merck KGaA Recent Development
Table 78. Novartis AG Company Detail
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Neurodegenerative Disease Treatment Product
Table 81. Novartis AG Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 82. Novartis AG Recent Development
Table 83. Pfizer, Inc. Company Detail
Table 84. Pfizer, Inc. Business Overview
Table 85. Pfizer, Inc. Neurodegenerative Disease Treatment Product
Table 86. Pfizer, Inc. Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 87. Pfizer, Inc. Recent Development
Table 88. Sanofi Company Detail
Table 89. Sanofi Business Overview
Table 90. Sanofi Neurodegenerative Disease Treatment Product
Table 91. Sanofi Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Teva Pharmaceutical Industries Ltd. Company Detail
Table 94. Teva Pharmaceutical Industries Ltd. Business Overview
Table 95. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product
Table 96. Teva Pharmaceutical Industries Ltd. Revenue in Neurodegenerative Disease Treatment Business (2018-2023) & (US$ Million)
Table 97. Teva Pharmaceutical Industries Ltd. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurodegenerative Disease Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neurodegenerative Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. Neurotransmitter Agents Features
Figure 4. Neuroprotective Agents Features
Figure 5. Biologics Features
Figure 6. Others Features
Figure 7. Global Neurodegenerative Disease Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Neurodegenerative Disease Treatment Market Share by Application: 2022 VS 2033
Figure 9. Multiple Sclerosis [MS] Case Studies
Figure 10. Alzheimer’s Disease Case Studies
Figure 11. Parkinson's Disease Case Studies
Figure 12. Acute Migraine Case Studies
Figure 13. Autism Case Studies
Figure 14. Narcolepsy Case Studies
Figure 15. Amyotrophic Lateral Sclerosis [ALS] Case Studies
Figure 16. Attention Deficit Hyperactivity Disorder [ADHD] Case Studies
Figure 17. Spinal Muscular Atrophy Case Studies
Figure 18. Huntington's Disease Case Studies
Figure 19. Neurodegenerative Disease Treatment Report Years Considered
Figure 20. Global Neurodegenerative Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Neurodegenerative Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Neurodegenerative Disease Treatment Market Share by Region: 2022 VS 2033
Figure 23. Global Neurodegenerative Disease Treatment Market Share by Players in 2022
Figure 24. Global Top Neurodegenerative Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Treatment Revenue in 2022
Figure 26. North America Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Neurodegenerative Disease Treatment Market Share by Country (2018-2033)
Figure 28. United States Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Neurodegenerative Disease Treatment Market Share by Country (2018-2033)
Figure 32. Germany Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Neurodegenerative Disease Treatment Market Share by Region (2018-2033)
Figure 40. China Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Neurodegenerative Disease Treatment Market Share by Country (2018-2033)
Figure 48. Mexico Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Neurodegenerative Disease Treatment Market Share by Country (2018-2033)
Figure 52. Turkey Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Neurodegenerative Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Allergan plc Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 55. Bayer AG Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 56. F. Hoffmann La-Roche Ltd. Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 59. Merck KGaA Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 61. Pfizer, Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Neurodegenerative Disease Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed